Target Prioritization

By combining evidence from multiple hetero-geneous experiments it is possible to better prioritize gene or drug candidates. We have extensive experience in integrating data across experimental platforms, including genomics, transcriptomics, and proteomics. Additionally, we can combine your proprietary data with the vast amounts of information stored in publicly available databases to increase their value.